戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rgery patients-in particular, depression and binge eating disorder.
2 stigation towards pharmacologically treating binge eating disorder.
3 trial to test the efficacy of sibutramine in binge eating disorder.
4 e in risk is specific for the development of binge eating disorder.
5 al abuse and discrimination) in the risk for binge eating disorder.
6 ctive and well tolerated in the treatment of binge eating disorder.
7 e efficacy of sertraline in the treatment of binge eating disorder.
8 jor eating disorders and a related syndrome, Binge Eating Disorder.
9 se female patients meeting full criteria for binge eating disorder.
10 ppressant d-fenfluramine in the treatment of binge eating disorder.
11 requency of binge eating by obese women with binge eating disorder.
12 and topiramate reduced weight in adults with binge-eating disorder.
13 he characteristic symptomatology observed in binge-eating disorder.
14 as a potential pharmacological treatment for binge-eating disorder.
15 o time did any participant meet criteria for binge-eating disorder.
16 f efficacy in adults with moderate to severe binge-eating disorder.
17 ns of anorexia nervosa, bulimia nervosa, and binge-eating disorder.
18 ns of anorexia nervosa, bulimia nervosa, and binge-eating disorder.
19 t outcome measures in the acute treatment of binge-eating disorder.
20  efficacy of fluvoxamine in the treatment of binge-eating disorder.
21 derstanding of the etiology and treatment of binge eating disorders.
22  were depression (19% [95% CI, 14%-25%]) and binge eating disorder (17% [95% CI, 13%-21%]).
23 ies reporting pharmacological treatments for binge eating disorder, advances in treatment for adults
24                                              Binge-eating disorder aggregated strongly in families in
25 N=4, 0.4%) met criteria for bulimia nervosa; binge eating disorder also was more common among white w
26 f 300 overweight or obese probands (150 with binge eating disorder and 150 with no lifetime eating di
27         A community sample of 162 women with binge eating disorder and 251 healthy and 107 psychiatri
28 d bulimia nervosa and more likely to exhibit binge eating disorder and eating disorder not otherwise
29 ating and obesity, emphasizing binge eating, binge eating disorder and food addiction as useful conce
30 5 and 5 y of follow-up, 134 individuals with binge-eating disorder and 134 individuals with no histor
31 o assess longitudinally the relation between binge-eating disorder and components of the metabolic sy
32 ries are: anorexia nervosa, bulimia nervosa, binge eating disorder, and eating disorder not otherwise
33               The best treatment options for binge-eating disorder are unclear.
34 sa and bulimia nervosa; and the inclusion of binge eating disorder as a formal diagnosis.
35 y of research also supports the inclusion of binge eating disorder as a formal diagnosis.
36 port for conceptualizing bulimia nervosa and binge eating disorder as discrete syndromes.
37 s to evaluate topiramate in the treatment of binge eating disorder associated with obesity.
38 ell tolerated in the short-term treatment of binge eating disorder associated with obesity.
39 l survey, the average lifetime prevalence of binge eating disorder (BED) was 2%.
40 dexamfetamine dimesylate (LDX) vs placebo in binge eating disorder (BED) was evaluated in two multice
41 teen obese individuals seeking treatment for binge eating disorder (BED) were compared with 19 non-BE
42  subjects with (n = 30) and without (n = 30) binge eating disorder (BED) were compared with matched h
43 ents the criterion standard for treatment of binge eating disorder (BED), most individuals do not hav
44 ide the United States on the epidemiology of binge eating disorder (BED).
45 IPT) is an effective specialty treatment for binge eating disorder (BED).
46 n phenotypes: pathological gambling (PG) and binge eating disorder (BED).
47 has documented efficacy for the treatment of binge eating disorder (BED).
48                                              Binge-eating disorder (BED) is characterized by recurrin
49                                              Binge-eating disorder (BED), a public health problem ass
50 l or food, in alcohol use disorders (AUD) or binge-eating disorder (BED), suggest a disturbance in ex
51                                              Binge-eating disorder (BED)-a syndrome that only recentl
52                                   Women with binge-eating disorder (BED; n = 38) and age- and weight-
53                                   Women with binge-eating disorder before and during pregnancy had hi
54 a before and during pregnancy and those with binge-eating disorder before pregnancy exhibit dietary p
55 sorder and 2.9% had partial or full-criteria binge eating disorder but no association with the outcom
56 or attention deficit hyperactivity disorder, binge eating disorder, cocaine addiction, obesity, and t
57 ade for atypical eating disorders except for binge-eating disorder (cognitive behavioural therapy was
58 trol disorders, including gambling disorder, binge eating disorder, compulsive sexual behaviour, and
59                 Eligible adults met DSM-IV-R binge-eating disorder criteria and had moderate to sever
60 up intakes of women with bulimia nervosa and binge-eating disorder during pregnancy and compared thes
61                          Women with incident binge-eating disorder during pregnancy had higher intake
62 disorder criteria and had moderate to severe binge eating disorder (>/=3 binge-eating days per week f
63 sibutramine is effective in the treatment of binge eating disorder, impacting both binge eating and w
64         This study assessed the stability of binge eating disorder in a community sample.
65 ce of anorexia nervosa, bulimia nervosa, and binge eating disorder in a geographically and economical
66 ciated with an increased risk for developing binge eating disorder in black women and in white women
67   Our findings support a distinct subtype of binge eating disorder in obesity with similarities in ri
68 comparison of individuals with and without a binge-eating disorder in analyses adjusted for age, sex,
69 ncts to psychotherapy for bulimia nervosa or binge-eating disorder; in the case of anorexia nervosa,
70                             The Internet and Binge Eating Disorder (INTERBED) study is a prospective,
71                                              Binge eating disorder is an addiction-like disorder char
72                                              Binge eating disorder is associated with obesity.
73                  These findings suggest that binge eating disorder is at least as chronic as the well
74                                              Binge-eating disorder is a familial disorder caused in p
75                                              Binge-eating disorder is a newly described eating disord
76                                              Binge-eating disorder is characterized by excessive, unc
77 led group cognitive-behavioral treatment for binge eating disorder led to higher binge eating abstine
78                                              Binge-eating disorder may confer a risk of components of
79                                              Binge-eating disorder may represent a risk factor for th
80 s among relatives with lifetime diagnoses of binge eating disorder (N=131), bulimia nervosa (N=17), a
81 gnosis of anorexia nervosa, bulimia nervosa, binge eating disorder, or eating disorder not otherwise
82                          In black women with binge eating disorder, rates of sexual abuse, physical a
83                          White subjects with binge eating disorder reported significantly higher rate
84                                              Binge eating disorder represents a public health problem
85 n the anticipation of rewards, subjects with binge eating disorder show greater risk-taking, similar
86 ere significantly higher in white women with binge eating disorder than in matched psychiatric compar
87 ere significantly higher in black women with binge eating disorder than in psychiatric comparison sub
88 pled with a lack of control over eating, and binge eating disorder, the Diagnostic and Statistical Ma
89  was to compare three types of treatment for binge eating disorder to determine the relative efficacy
90                The mean lifetime duration of binge eating disorder was 14.4 years (SD=13.9), signific
91                       Neither depression nor binge eating disorder was consistently associated with d
92         A total of 259 adults diagnosed with binge eating disorder were randomly assigned to 20 weeks
93 icipants (N=304) who met DSM-IV criteria for binge eating disorder were randomly assigned to 24 weeks
94          Thirty-four outpatients with DSM-IV binge eating disorder were randomly assigned to receive
95                         Anorexia nervosa and binge eating disorder were relatively uncommon.
96 es of anorexia nervosa, bulimia nervosa, and binge-eating disorder were 0.3%, 0.9%, and 1.6%, respect
97 -five outpatients with a DSM-IV diagnosis of binge-eating disorder were randomly assigned to receive
98 l, 61 outpatients (53 women, eight men) with binge eating disorder who were obese (body mass index >/
99 tablished treatments for bulimia nervosa and binge eating disorder, with stepped-care approaches show

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。
 
コーパス検索結果について
ご利用ガイド
ご利用規定
新規対訳・お問い合わせ
Copyright 1993 - ライフサイエンス辞書プロジェクト